HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Elli Stefanadi Selected Research

Bevacizumab (Avastin)

5/2008Avastin-eluting stent: long-term angiographic and clinical follow up.
1/2008First-in-man study with bevacizumab-eluting stent: a new approach for the inhibition of atheromatic plaque neovascularisation.
12/2007Inhibition of plaque neovascularization and intimal hyperplasia by specific targeting vascular endothelial growth factor with bevacizumab-eluting stent: an experimental study.
1/2006First experimental application of bevacizumab-eluting PC coated stent for inhibition of vasa vasorum of atherosclerotic plaque: angiographic results in a rabbit atheromatic model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Elli Stefanadi Research Topics

Disease

12Atherosclerosis
05/2011 - 05/2006
8Inflammation (Inflammations)
06/2010 - 06/2007
7Heart Failure
06/2010 - 02/2007
5Hypertension (High Blood Pressure)
11/2011 - 04/2007
5Cardiovascular Diseases (Cardiovascular Disease)
03/2011 - 10/2007
5Myocardial Infarction
03/2011 - 05/2006
5Coronary Artery Disease (Coronary Atherosclerosis)
11/2008 - 05/2007
4Hyperemia
06/2009 - 05/2006
3Type 2 Diabetes Mellitus (MODY)
05/2011 - 06/2007
3Diabetes Mellitus
05/2011 - 03/2008
3Thrombosis (Thrombus)
03/2011 - 10/2008
3Albuminuria
06/2010 - 10/2008
2Homocysteinemia
08/2011 - 06/2008
2ST Elevation Myocardial Infarction
06/2011 - 04/2009
2Essential Hypertension
06/2010 - 06/2010
2Stable Angina
03/2008 - 11/2007
2Hyperplasia
01/2008 - 12/2007
1Rupture
06/2011
1Non-ST Elevated Myocardial Infarction
06/2011
1Chronic Renal Insufficiency
03/2011
1Muscular Diseases (Myopathy)
09/2010
1Gastrointestinal Diseases (Functional Gastrointestinal Disorders)
09/2010
1Muscle Cramp (Cramp)
09/2010
1Atrial Fibrillation
06/2010
1Insulin Resistance
01/2010
1Obesity
01/2010
1Periodontal Diseases (Periodontal Disease)
01/2010
1Embolic Stroke
12/2009
1Acute-Phase Reaction
05/2009
1Dyslipidemias (Dyslipidemia)
04/2009
1Infections
11/2008
1Hepatitis A (Hepatitis, Infectious)
11/2008
1Erectile Dysfunction
09/2008
1Body Weight (Weight, Body)
06/2008
1Pathologic Constriction (Stenosis)
05/2008
1Chest Pain (Chest Pains)
03/2008

Drug/Important Bio-Agent (IBA)

6Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
05/2011 - 02/2007
5Atorvastatin (Lipitor)FDA Link
05/2011 - 06/2007
5C-Reactive ProteinIBA
06/2010 - 06/2007
4CytokinesIBA
05/2009 - 06/2007
4Bevacizumab (Avastin)FDA Link
05/2008 - 01/2006
3N,N-dimethylarginine (asymmetric dimethylarginine)IBA
11/2011 - 09/2008
3LipidsIBA
06/2011 - 05/2006
3AlbuminsIBA
06/2010 - 10/2008
3Proteins (Proteins, Gene)FDA Link
06/2010 - 01/2008
3Arginine (L-Arginine)FDA Link
01/2010 - 04/2007
2VitaminsIBA
08/2011 - 06/2008
2Methionine (L-Methionine)FDA Link
08/2011 - 06/2008
2Glucose (Dextrose)FDA LinkGeneric
05/2011 - 09/2010
2Metformin (Glucophage)FDA LinkGeneric
05/2011 - 09/2010
2omega-Chloroacetophenone (Mace)IBA
03/2011 - 10/2008
2CreatinineIBA
06/2010 - 10/2008
2Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
04/2010 - 08/2008
2Biomarkers (Surrogate Marker)IBA
12/2009 - 01/2008
2Interleukin-6 (Interleukin 6)IBA
04/2009 - 09/2008
2Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
04/2009 - 06/2008
1OsteoprotegerinIBA
11/2011
1dimethylarginineIBA
08/2011
1AntioxidantsIBA
08/2011
1Phenobarbital (Luminal)FDA Link
06/2011
1Blood Glucose (Blood Sugar)IBA
09/2010
1EnzymesIBA
09/2010
1Rosuvastatin Calcium (Crestor)FDA Link
06/2010
1Ezetimibe (Zetia)FDA Link
06/2010
1ResistinIBA
06/2010
1Antidepressive Agents (Antidepressants)IBA
04/2010
1Angiotensin IIIBA
03/2010
1Type 2 Angiotensin ReceptorIBA
03/2010
1AdipokinesIBA
01/2010
1Olive OilIBA
01/2010
1Soybean OilFDA LinkGeneric
01/2010
1Corn Oil (Oil, Corn)IBA
01/2010
1Cod Liver OilIBA
01/2010
1Interleukin-1beta (Interleukin 1 beta)IBA
06/2009
1NitratesIBA
06/2009
1Acute-Phase Proteins (Acute-Phase Protein)IBA
05/2009
1Tissue Plasminogen Activator (Alteplase)FDA Link
04/2009
1Plasminogen Activators (Plasminogen Activator)IBA
04/2009
1von Willebrand FactorIBA
04/2009
1LDL Lipoproteins (beta Lipoproteins)IBA
04/2009
1Simendan (Levosimendan)IBA
02/2009
1Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
12/2008
1Immunoglobulin G (IgG)IBA
11/2008
1Immunoglobulin M (IgM)IBA
11/2008
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2008
1Hepatitis A AntibodiesIBA
11/2008
1Immunoglobulin A (IgA)IBA
11/2008
1AntibodiesIBA
11/2008
1Cardiovascular AgentsIBA
08/2008
1HomocysteineIBA
06/2008
1oxidized low density lipoproteinIBA
06/2008
1IrbesartanFDA LinkGeneric
02/2008
1PerindoprilFDA LinkGeneric
02/2008

Therapy/Procedure

6Stents
03/2011 - 01/2006
3Drug-Eluting Stents
03/2011 - 11/2007
2Coronary Artery Bypass (Coronary Artery Bypass Surgery)
03/2008 - 11/2007
1Therapeutics
05/2011
1Electric Countershock (Cardioversion)
12/2009
1Percutaneous Coronary Intervention
03/2008
1Length of Stay
03/2008